Lack of Approved Therapies Highlights Challenges in Vaping Cessation
• E-cigarettes, initially seen as a smoking cessation tool, have led to a new wave of nicotine addiction, with many users finding it difficult to quit vaping.
• The FDA has not approved e-cigarettes for smoking cessation, and there is a lack of data on effective methods to stop vaping, creating a significant unmet need.
• Achieve Life Sciences is developing cytisinicline, a potential first-in-class medication for vaping cessation, which has received Breakthrough Therapy designation from the FDA.
• Alternative methods like nicotine pouches are being used to wean off vaping, but experts advise a short-term approach to avoid prolonged nicotine dependence.
© Copyright 2025. All Rights Reserved by MedPath